Figure 1From: Proteome characterization of a human urothelial cell line resistant to the bladder carcinogen 4-aminobiphenylCytotoxicity curves for human bladder cancer cell line RT112 and 4-ABP resistant clones RT5 and RT11 after the first 4-ABP treatment panel (A); after the second 4-ABP treatment, panel (B).Back to article page